Company intelligence / Profile preview

Currax Pharmaceuticals LLC

Brentwood, Tennessee, United Statescurraxpharma.com ↗
Ownership
Private
Employees
~100
Development stage
Commercial
01

Overview

Currax Pharmaceuticals distributes FDA-approved medications including CONTRAVE (the #1 prescribed branded oral weight-loss medication in the US), ONZETRA Xsail, Silenor, Treximet, and the authorized generic of Treximet.

Therapeutic areas
EndocrinologyPsychiatryNeurology
Modalities
Small molecule drugs
Industry
Biotech
02

Drug pipeline

11 assets

Rezira

Unknown

10 more assets in the full pipeline.

Beyond the preview

Go deeper on Currax Pharmaceuticals LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Currax Pharmaceuticals LLC.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call